bluebird bio, Inc. (NASDAQ:BLUE) Stock Position Lowered by JPMorgan Chase & Co.
JPMorgan Chase & Co. decreased its holdings in bluebird bio, Inc. (NASDAQ:BLUE – Free Report) by 91.8% during the fourth quarter, Holdings Channel.com reports. The firm owned 50,726 shares of the biotechnology company’s stock after selling 571,130 shares during the period. JPMorgan Chase & Co.’s holdings in bluebird bio were worth $423,000 as of its […]
JPMorgan Chase & Co. decreased its holdings in bluebird bio, Inc. (NASDAQ:BLUE – Free Report) by 91.8% during the fourth quarter, Holdings Channel.com reports. The firm owned 50,726 shares of the biotechnology company’s stock after selling 571,130 shares during the period. JPMorgan Chase & Co.’s holdings in bluebird bio were worth $423,000 as of its […]
